KLRC1 and neoplasm: Remarkably, NKG2A, a non-classical inhibitory receptor more typically associated with NK cells, was substantially increased in tumor-infiltrating CD8+ T cells, showing a 3.4-fold rise relative to peripheral blood (PBMCs: 5.9%; TILs: 20.1%) (Figure 3).